Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180943 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
A Phase 4 study of Anesthesia, Local, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT04180943: Completed Phase 4 study of Anesthesia, Local, sponsored by Bassett Healthcare.
NCT04180943 is a Phase 4 study of Anesthesia, Local that has completed, run by Bassett Healthcare. The registered enrollment target is 85 participants, roughly in line with the 78-participant average among 18 other Anesthesia, Local trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04180943, a Phase 4 study of Anesthesia, Local, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.
Primary Outcome
time to first post-operative pain medication
Conditions Studied
Interventions
- DRUG interscalene nerve block
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2019-12-13 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 4 |
What the finished NCT04180943 record still lists
NCT04180943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, roughly in line with the 78-participant average among 18 other Anesthesia, Local trials with a reported enrollment target.
The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 1 intervention - of which interscalene nerve block is the first listed.
NCT04180943 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04180943 about?
NCT04180943 is a clinical study titled "Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery". This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifica...
What is the current status of trial NCT04180943?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 85 participants. The study started on 2019-12-13. Estimated completion is 2021-06-01.
What conditions does trial NCT04180943 study?
This clinical trial studies the following conditions: Anesthesia, Local.
What interventions are being tested in trial NCT04180943?
The interventions under investigation include: interscalene nerve block (DRUG).
Who is sponsoring clinical trial NCT04180943?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04180943 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04180943's enrollment target sits among peer trials
85 6th of 18 higher than 13 of 18 other Anesthesia, Local trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia, Local trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
-
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
RECRUITING · Phase 4
-
Intralipid® 20% for Reversal of Local Anesthetics
ACTIVE NOT RECRUITING · Phase 4
-
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI